Insider Transactions in Q2 2021 at Fulgent Genetics, Inc. (FLGT)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 04
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
789
-0.55%
|
$58,386
$74.26 P/Share
|
|
Jun 03
2021
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
125
-5.88%
|
$9,250
$74.17 P/Share
|
|
Jun 02
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
461
-0.32%
|
$32,731
$71.34 P/Share
|
|
Jun 01
2021
|
John C Bolger Director |
SELL
Open market or private sale
|
Direct |
1,876
-46.89%
|
$133,196
$71.41 P/Share
|
|
Jun 01
2021
|
John C Bolger Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,876
+15.13%
|
$15,008
$8.52 P/Share
|
|
May 28
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
647
-0.19%
|
$47,231
$73.46 P/Share
|
|
May 26
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
18,000
-11.15%
|
$1,296,000
$72.9 P/Share
|
|
May 25
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
2,000
-0.59%
|
$144,000
$72.21 P/Share
|
|
May 25
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
10,358
-6.03%
|
$745,776
$72.94 P/Share
|
|
May 20
2021
|
John C Bolger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+48.48%
|
-
|
|
May 20
2021
|
Linda Marsh |
BUY
Grant, award, or other acquisition
|
Direct |
2,000
+50.0%
|
-
|
|
May 20
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
1,000
-0.29%
|
$74,000
$74.48 P/Share
|
|
May 18
2021
|
Hanlin Gao Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
315
-0.04%
|
$22,050
$70.71 P/Share
|
|
May 18
2021
|
Paul Kim CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
1,155
-0.67%
|
$80,850
$70.71 P/Share
|
|
May 18
2021
|
Jian Xie President and COO |
SELL
Open market or private sale
|
Direct |
931
-0.27%
|
$65,170
$70.71 P/Share
|
|
May 01
2021
|
Jian Xie President and COO |
SELL
Payment of exercise price or tax liability
|
Direct |
504
-0.15%
|
$38,808
$77.02 P/Share
|
|
Apr 30
2021
|
Hanlin Gao Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,500
+0.43%
|
-
|